51. The Role of Serum Matrix Metalloproteinase - 9 as a Prognostic Biomarker for Short-Term Outcome in Acute Ischemic Stroke.
- Author
-
Fathy, Hala A., Soliman, Ali M., Lotfy, Sabah M., and Omar, Wafeek E. K.
- Subjects
- *
ISCHEMIC stroke , *MATRIX metalloproteinases , *MYELIN proteins , *STROKE units , *INTENSIVE care units , *STROKE , *LACUNAR stroke - Abstract
Background: Stroke is a heterogeneous and multi-factorial disease that affects people globally. Matrix Metalloproteinase-9 is involved in blood- brain barrier breakdown, edema development, pro-inflammatory cytokine activation and destruction of myelin proteins are all connected to the pathogenic events that take place during an ischemic stroke., matrix metalloproteinase- 9 concentration is greatly related to infarct extension, neurologic impairments, and hemorrhagic transformation in individuals with ischemic stroke. Objective: We focused our research on improving individuals' outcomes after having an acute ischemic stroke by assessing the level of serum matrix metalloproteinase-9 24 hours after the stroke begins and the relation between Serum levels of matrix metalloproteinase-9, clinical severity, and ischemic stroke prognosis. Methods: This follow up prospective cohort research was conducted at Zagazig University Hospitals' Intensive Care Unit and Stroke Unit at the Neurology Department and Emergency Room. The study included 54 people experiencing their first acute ischemic stroke. Stroke severity and serum MMP-9 level were assessed on admission and following a 15-day follow-up. Results: Level of Serum MMP-9 was 1085.93 ng/ml with a range from 485 to 1544 ng/ml. Statistically significant positive correlation was found between serum MMP-9 and neurological severity as measured by NIHSS at admission and after 15 days. Also, there was a highly significant positive correlation between MMP-9 and functional outcome as assessed by mRS after 15 da ys follow up. The best cutoff of MMP-9 in prediction of large size infarction, that was ≥ 1042 Also, the best cutoff of MMP-9 in prediction of severe stroke was ≥ 1091 ng/ml. The best cutoff of MMP-9 in prediction of severe stroke after 15 days is ≥972.5 ng/ml. Among factors significantly correlated with baseline NIHSS, MMP-9, size of infarct, BI and mRS were significantly independently associated with baseline NIHSS among studied patients.Conclusion: Serum MMP-9 may act as potential prognostic factor predicting neurological severity and short term outcome in individuals with ischemic stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF